Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
Wilhelm Furnon, Vanessa M. Cowton, Giuditta De Lorenzo, et al.
Nature Microbiology (2025)
Open Access | Times Cited: 1
Nonhuman primate antigenic cartography of SARS-CoV-2
Annika Rössler, Antonia Netzl, Ninaad Lasrado, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115140-115140
Open Access
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection
Jun Liu, Li Wang, Alexandra Kurtesi, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections
Nungruthai Suntronwong, Sitthichai Kanokudom, Thaneeya Duangchinda, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression
Kimia Kamelian, Benjamín L. Sievers, Michael Chen‐Xu, et al.
Science Advances (2025) Vol. 11, Iss. 7
Open Access
SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasion
Wenjing Ruan, Pengyue Gao, Xiao Qu, et al.
EBioMedicine (2025) Vol. 114, pp. 105634-105634
Closed Access
Durability of protection from original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the United States — September 2022–August 2023
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray
David Niklas Springer, Eva Höltl, Katja Prüger, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 94-94
Open Access | Times Cited: 3
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera
Wei Wang, Gitanjali Bhushan, Stephanie Paz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates
Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1913-1927
Open Access | Times Cited: 3
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Deborah Cromer, Arnold Reynaldi, Ainslie Mitchell, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1
Wei Wang, Gitanjali Bhushan, Stephanie Paz, et al.
Journal of Virology (2024)
Closed Access | Times Cited: 2
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates
Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Antigenic Cartography of SARS-CoV-2
Ekaterina A. Astakhova, Alexey A. Morozov, Julia D. Vavilova, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 5, pp. 862-871
Closed Access | Times Cited: 1
Recent approaches in computational modelling for controlling pathogen threats
John A. Lees, Timothy Russell, Liam P. Shaw, et al.
Life Science Alliance (2024) Vol. 7, Iss. 9, pp. e202402666-e202402666
Open Access | Times Cited: 1
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity
Simone I. Richardson, Nonkululeko Mzindle, Thopisang Motlou, et al.
Journal of Virology (2024) Vol. 98, Iss. 7
Closed Access | Times Cited: 1
Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment
Matteo Augello, Isabell Wagenhäuser, Manuel Krone, et al.
Vaccine (2024) Vol. 42, Iss. 25, pp. 126184-126184
Closed Access | Times Cited: 1
Expanded immune imprinting and neutralization spectrum by hybrid immunization following breakthrough infections with SARS-CoV-2 variants after three-dose vaccination
Tingting Jia, Fuxiang Wang, Y Chen, et al.
Journal of Infection (2024) Vol. 89, Iss. 6, pp. 106362-106362
Open Access | Times Cited: 1
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Deborah Cromer, Arnold Reynaldi, Ainslie Hie, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA.2.86
S. Richard Turner, Gayatri Amirthalingam, Dalan Bailey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
Wilhelm Furnon, Vanessa M. Cowton, Giuditta De Lorenzo, et al.
Research Square (Research Square) (2024)
Open Access
SARS-CoV-2-Neutralizing Antibodies
Yawen Liu, Jianhui Nie
Vaccines (2024) Vol. 12, Iss. 11, pp. 1256-1256
Open Access
Studying bats using a One Health lens: bridging the gap between bat virology and disease ecology
Victoria Gonzalez, Arianna M. Hurtado-Monzón, Sabrina O'Krafka, et al.
Journal of Virology (2024)
Closed Access
CovTransformer: A transformer model for SARS-CoV-2 lineage frequency forecasting
Yinan Feng, Emma E. Goldberg, Michael D. Kupperman, et al.
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top